These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27918244)

  • 21. Association of genetic variants in six candidate genes with valproic acid therapy optimization.
    Hung CC; Ho JL; Chang WL; Tai JJ; Hsieh TJ; Hsieh YW; Liou HH
    Pharmacogenomics; 2011 Aug; 12(8):1107-17. PubMed ID: 21806385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of CYP2C9-status guided valproic acid therapy in children.
    Bűdi T; Tóth K; Nagy A; Szever Z; Kiss Á; Temesvári M; Háfra E; Garami M; Tapodi A; Monostory K
    Epilepsia; 2015 Jun; 56(6):849-55. PubMed ID: 25967074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of SCN2A c.56G/A Gene Polymorphism in Egyptian Children with Genetic Epilepsy with Febrile Seizure Plus.
    Berseem NF; Khattab ESAEH; Saad DS; Abd Elnaby SA
    CNS Neurol Disord Drug Targets; 2022; 21(5):450-457. PubMed ID: 34607551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of
    Du Z; Xu H; Zhao P; Wang J; Xu Q; Liu M
    Xenobiotica; 2021 Jul; 51(7):859-864. PubMed ID: 34000957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients.
    Bai X; Xu C; Wen D; Chen Y; Li H; Wang X; Zhou L; Huang M; Jin J
    Psychopharmacology (Berl); 2018 Sep; 235(9):2665-2673. PubMed ID: 29984389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid.
    Li H; Wang X; Zhou Y; Ni G; Su Q; Chen Z; Chen Z; Li J; Chen X; Hou X; Xie W; Xin S; Zhou L; Huang M
    Int J Neuropsychopharmacol; 2015 Mar; 18(7):pyv021. PubMed ID: 25740917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case-control study and meta-analysis.
    Wang ZJ; Chen J; Chen HL; Zhang LY; Xu D; Jiang WT
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients.
    Haerian BS; Lim KS; Tan HJ; Mohamed EH; Tan CT; Raymond AA; Wong CP; Wong SW; Omar H; Roslan H; Mohamed Z
    Epileptic Disord; 2011 Mar; 13(1):65-75. PubMed ID: 21388909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis.
    Ogusu N; Saruwatari J; Nakashima H; Noai M; Nishimura M; Deguchi M; Oniki K; Yasui-Furukori N; Kaneko S; Ishitsu T; Nakagaswa K
    PLoS One; 2014; 9(11):e111066. PubMed ID: 25372290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy.
    Wang C; Wang P; Yang LP; Pan J; Yang X; Ma HY
    Epilepsy Res; 2017 May; 132():64-69. PubMed ID: 28315807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABCC2 rs2273697 is associated with valproic acid concentrations in patients with epilepsy on valproic acid monotherapy.
    Chen J; Su QB; Tao YQ; Qin JM; Zhou Y; Zhou S; Li HL; Chen ZJ; Zhou YF; Zhou LM; Wang XD; Huang M
    Pharmazie; 2018 May; 73(5):279-282. PubMed ID: 29724294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.
    Chu XM; Zhang LF; Wang GJ; Zhang SN; Zhou JH; Hao HP
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1395-401. PubMed ID: 22476391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
    Chung S; Choi J; Hyun T; Rha Y; Bae C
    J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy.
    Kim SH; Chung HR; Kim SH; Kim H; Lim BC; Chae JH; Kim KJ; Hwang YS; Hwang H
    Neuropediatrics; 2012 Jun; 43(3):135-9. PubMed ID: 22618302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Color vision in epileptic adolescents treated with valproate and carbamazepine.
    Verrotti A; Lobefalo L; Priolo T; Rapinese M; Trotta D; Morgese G; Gallenga PE; Chiarelli F
    Seizure; 2004 Sep; 13(6):411-7. PubMed ID: 15276145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium valproate for epilepsy in rural China: an efficacy and safety assessment in primary care.
    Wang W; Wu J; Li S; Ru X; Zheng J; Zhu S; Sander JW
    Epilepsy Res; 2012 Dec; 102(3):201-5. PubMed ID: 22809651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.